Inspirata, Inc

We are Inspirata, a leading oncology informatics company dedicated to transforming cancer care through innovative digital pathology, cancer registry, and clinical research solutions. Our mission is to integrate and streamline the complex workflows involved in cancer diagnosis, treatment, and research, leveraging advanced artificial intelligence (AI) and natural language processing (NLP) technologies. We empower healthcare institutions, pathologists, oncologists, and researchers with the tools needed to enhance efficiency, improve data utilization, and ultimately accelerate the path to better patient outcomes.

Our core offerings include comprehensive digital pathology solutions designed to revolutionize the diagnostic workflow. The Dynamo™ Digital Pathology Assistant System (DPAS) provides an integrated platform for image management, workflow orchestration, and diagnostic reporting. This ecosystem includes our universal Dynamo™ Viewer, enabling seamless access and review of whole slide images, along with a suite of Dynamo™ AI Algorithms that assist in quantitative analysis and detection. We also provide Digital Pathology as a Service (DPaaS), supporting institutions in their journey towards fully digital pathology labs, from infrastructure to implementation and ongoing support.

Beyond digital pathology, we are pioneers in cancer registry automation and management. The Inspirata Cancer Registry™ is a robust solution that simplifies the complex process of data collection, abstraction, and reporting for cancer programs. Utilizing sophisticated AI and NLP, our platform automates critical aspects of data abstraction from disparate clinical systems, significantly reducing manual effort and improving data accuracy. This comprehensive registry solution ensures compliance with regulatory standards and provides valuable insights for quality improvement, epidemiological research, and operational efficiency within cancer centers.

Furthermore, we extend our expertise into clinical research, providing solutions that accelerate discovery and improve patient access to advanced therapies. Our clinical trial matching platform leverages AI and NLP to precisely match cancer patients with eligible clinical trials based on their specific clinical and genomic profiles. This capability, combined with our ability to curate and analyze real-world data (RWD), empowers researchers and pharmaceutical companies to identify patient cohorts, optimize trial design, and gain deeper insights into disease progression and treatment efficacy, thereby driving forward precision oncology.

At Inspirata, we are committed to providing integrated, end-to-end solutions that span the entire cancer care continuum. From primary diagnosis and registry management to clinical research and patient matching, our technology is built to create a more connected, data-driven, and efficient environment. We strive to be the trusted partner for oncology programs seeking to harness the power of AI and digital transformation to deliver superior care and advance the fight against cancer.